Study summary · research use only
The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analysis, different bioassays and immunoassay
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study (species not specified) examined the International Reference Preparation of Gonadorelin for Bioassay (IRP, coded 77/596), comparing it with synthetic luteinizing hormone releasing hormone (LH-RH) preparations from different manufacturers using thin-layer chromatography, reverse-phase HPLC, various bioassays, and immunoassay across four laboratories. Chromatography indicated some heterogeneity in most LH-RH preparations, with the IRP judged 88.3% (w/w) pure by HPLC; each ampoule was estimated to contain approximately 31 nmol LH-RH. The IRP behaved similarly to other LH-RH preparations across bioassays, and biological activities correlated with physicochemical purity measures. The World Health Organization established the ampouled preparation, coded 77/596, as the International Reference Preparation of Gonadorelin for Bioassay, assigned a unitage of 31 i.u./ampoule based on 1 nmole of LH-RH representing 1 i.u.
Abstract
The preparation and nature of the International Reference Preparation of Gonadorelin for Bioassay (IRP; coded 77/596) are described. The IRP was studied by four laboratories in four countries and compared, using physicochemical methods of analysis, various bioassay procedures and immunoassay, with preparations of synthetic luteinizing hormone releasing hormone (LH-RH) produced by different manufacturers. Analyses by thin-layer chromatography and by reverse-phase high-performance liquid chromatography (HPLC) indicated some heterogeneity of the peptide present in most of these preparations of synthetic LH-RH, including that of the IRP; the latter preparation appeared to be 88.3% (w/w) pure, judged by HPLC. The data from the collaborative study suggested that each ampoule of the IRP contains approximately 31 nmol LH-RH. The IRP appeared to be suitable to serve as an international reference preparation for bioassay since its behaviour was similar in different bioassays, so far as this could be examined, to that of the other preparations of LH-RH with which it was compared. Furthermore, the biological activities of different preparations of LH-RH, assessed in terms of the IRP, appeared to correlate with their degrees of purify assessed by physicochemical methods, suggesting that the peptides other than LH-RH present in the IRP did not contribute significantly to the biological activity of the preparation in these assay procedures. The limited data available suggested that the IRP might also be suitable as a reference preparation for immunoassay. The ampouled preparation, coded 77/596, was therefore established by the World Health Organization as the International Reference Preparation of Gonadorelin for Bioassay and assigned a unitage of 31 i.u./ampoule on the basis that the i.u. is represented by 1 nmole of LH-RH.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.